SCHEMBL30700136

SCHEMBL30700136

O=CN1CC[C@H](c2cnn[nH]2)C1

nearest known ligand 0.34

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31308011 1.00 PDE4B (0.34) PDE4B
SCHEMBL31308079 0.75 HSD11B1 (0.43) PDE4B
SCHEMBL31308066 0.75 HRH3 (0.47)
SCHEMBL15431905 0.71 DRD4 (0.43)
SCHEMBL16828882 0.71
SCHEMBL31308054 0.70 PDE4B (0.33) PDE4B
SCHEMBL31308077 0.69 PDE4B (0.34) PDE4B
SCHEMBL16828890 0.68
SCHEMBL19308651 0.68
SCHEMBL7829206 0.66 RAB9A (0.49) PDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4543870-A1 NEW HETEROCYCLIC-CARBONYL-CYCLIC COMPOUNDS AS MAGL INHIBITORS F. Hoffmann-La Roche AG (CH) 2025-04-30 EP claimed
WO-2023247670-A1 NEW HETEROCYCLIC-CARBONYL-CYCLIC COMPOUNDS AS MAGL INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2023-12-28 WO claimed